Skip to main content
Erschienen in: Japanese Journal of Radiology 1/2017

11.10.2016 | Original Article

Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?

verfasst von: Berna A. Yildirim, Cem Onal, Yemliha Dolek

Erschienen in: Japanese Journal of Radiology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare soft-tissue cone-beam computed tomography (CBCT-P) and fiducial marker (CBCT-FM)-based image guided radiotherapy in prostate cancer patients.

Materials and methods

Sixteen prostate cancer patients were treated with volumetric modulated arc therapy. Manual alignment using CBCT-P and CBCT-FM was performed for each patient. Couch shifts were calculated and compared between methods in the left–right (x), superior–inferior (y), and anterior–posterior (z) directions.

Results

CBCT-P and CBCT-FM alignments were compared using 252 scans from the 16 patients. Mean displacement from zero was 2.4 ± 1.3, 1.7 ± 1.2, and 1.8 ± 1.1 mm for CBCT-P and 2.3 ± 1.3, 1.7 ± 1.1 and 1.8 ± 1.1 mm for CBCT-FM in the x, y and z directions, respectively. There was no difference in median displacement between CBCT-P and CBCT-FM; however, there was a significant positive correlation between CBCT-P- and CBCT-FM-based displacements in the x (r = 0.881; p < 0.001), y (r = 0.789; p < 0.001) and z (r = 0.856; p < 0.001) directions by linear regression analysis. Systematic deviations within each group were <1 mm; however, random and systematic errors were similar in the x and y directions but larger in the z direction.

Conclusion

Our study demonstrated that CBCT-FM was not superior to CBCT-P for image-guided radiotherapy in prostate cancer patients.
Literatur
1.
Zurück zum Zitat Rosenthal SA, Sandler HM. Treatment strategies for high-risk locally advanced prostate cancer. Nat Rev Urol. 2010;7(1):31–8.CrossRefPubMed Rosenthal SA, Sandler HM. Treatment strategies for high-risk locally advanced prostate cancer. Nat Rev Urol. 2010;7(1):31–8.CrossRefPubMed
2.
Zurück zum Zitat Pisansky TM. External-beam radiotherapy for localized prostate cancer. N Engl J Med. 2006;355(15):1583–91.CrossRefPubMed Pisansky TM. External-beam radiotherapy for localized prostate cancer. N Engl J Med. 2006;355(15):1583–91.CrossRefPubMed
3.
Zurück zum Zitat Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67–74.CrossRefPubMed Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67–74.CrossRefPubMed
4.
Zurück zum Zitat Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72(4):980–8.CrossRefPubMed Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72(4):980–8.CrossRefPubMed
5.
Zurück zum Zitat Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475–87.CrossRefPubMed Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475–87.CrossRefPubMed
6.
Zurück zum Zitat Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294(10):1233–9.CrossRefPubMed Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294(10):1233–9.CrossRefPubMed
7.
Zurück zum Zitat Cahlon O, Hunt M, Zelefsky MJ. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol. 2008;18(1):48–57.CrossRefPubMed Cahlon O, Hunt M, Zelefsky MJ. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol. 2008;18(1):48–57.CrossRefPubMed
8.
Zurück zum Zitat Button MR, Staffurth JN. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol (R Coll Radiol). 2010;22(8):698–706.CrossRef Button MR, Staffurth JN. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol (R Coll Radiol). 2010;22(8):698–706.CrossRef
9.
Zurück zum Zitat Peeters ST, Lebesque JV, Heemsbergen WD, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64(4):1151–61.CrossRefPubMed Peeters ST, Lebesque JV, Heemsbergen WD, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64(4):1151–61.CrossRefPubMed
10.
Zurück zum Zitat Morr J, DiPetrillo T, Tsai JS, et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53(5):1124–9.CrossRefPubMed Morr J, DiPetrillo T, Tsai JS, et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53(5):1124–9.CrossRefPubMed
11.
Zurück zum Zitat Frank SJ, Dong L, Kudchadker RJ, et al. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008;71(3):813–20.CrossRefPubMed Frank SJ, Dong L, Kudchadker RJ, et al. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008;71(3):813–20.CrossRefPubMed
12.
Zurück zum Zitat Welsh JS, Berta C, Borzillary S, et al. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technol Cancer Res Treat. 2004;3(4):359–64.CrossRefPubMed Welsh JS, Berta C, Borzillary S, et al. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technol Cancer Res Treat. 2004;3(4):359–64.CrossRefPubMed
13.
Zurück zum Zitat Dehnad H, Nederveen AJ, van der Heide UA, et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol. 2003;67(3):295–302.CrossRefPubMed Dehnad H, Nederveen AJ, van der Heide UA, et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol. 2003;67(3):295–302.CrossRefPubMed
14.
Zurück zum Zitat Snir JA, Battista JJ, Bauman G, et al. Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy. Clin Oncol (R Coll Radiol). 2011;23(9):625–31.CrossRef Snir JA, Battista JJ, Bauman G, et al. Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy. Clin Oncol (R Coll Radiol). 2011;23(9):625–31.CrossRef
15.
Zurück zum Zitat Bylund KC, Bayouth JE, Smith MC, et al. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;72(3):949–56.CrossRefPubMed Bylund KC, Bayouth JE, Smith MC, et al. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;72(3):949–56.CrossRefPubMed
16.
Zurück zum Zitat Nichol AM, Brock KK, Lockwood GA, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2007;67(1):48–56.CrossRefPubMed Nichol AM, Brock KK, Lockwood GA, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2007;67(1):48–56.CrossRefPubMed
17.
Zurück zum Zitat Jaffray DA, Siewerdsen JH. Cone-beam computed tomography with a flat-panel imager: initial performance characterization. Med Phys. 2000;27(6):1311–23.CrossRefPubMed Jaffray DA, Siewerdsen JH. Cone-beam computed tomography with a flat-panel imager: initial performance characterization. Med Phys. 2000;27(6):1311–23.CrossRefPubMed
18.
Zurück zum Zitat Ding GX, Duggan DM, Coffey CW, et al. A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiother Oncol. 2007;85(1):116–25.CrossRefPubMed Ding GX, Duggan DM, Coffey CW, et al. A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiother Oncol. 2007;85(1):116–25.CrossRefPubMed
19.
Zurück zum Zitat Greer PB, Dahl K, Ebert MA, et al. Comparison of prostate set-up accuracy and margins with off-line bony anatomy corrections and online implanted fiducial-based corrections. J Med Imaging Radiat Oncol. 2008;52(5):511–6.CrossRefPubMed Greer PB, Dahl K, Ebert MA, et al. Comparison of prostate set-up accuracy and margins with off-line bony anatomy corrections and online implanted fiducial-based corrections. J Med Imaging Radiat Oncol. 2008;52(5):511–6.CrossRefPubMed
20.
Zurück zum Zitat Onal C, Arslan G, Parlak C, et al. Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer. Jpn J Radiol. 2014;32(4):224–32.CrossRefPubMed Onal C, Arslan G, Parlak C, et al. Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer. Jpn J Radiol. 2014;32(4):224–32.CrossRefPubMed
21.
Zurück zum Zitat Onal C, Topkan E, Efe E, et al. Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. Radiat Oncol. 2009;4:14.CrossRefPubMedPubMedCentral Onal C, Topkan E, Efe E, et al. Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. Radiat Oncol. 2009;4:14.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–7.CrossRefPubMed Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–7.CrossRefPubMed
23.
Zurück zum Zitat Berkovic P, De Meerleer G, Delrue L, et al. Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer. 2013;11(1):27–32.CrossRefPubMed Berkovic P, De Meerleer G, Delrue L, et al. Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer. 2013;11(1):27–32.CrossRefPubMed
24.
Zurück zum Zitat Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995;346(8982):1085–7.CrossRefPubMed Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995;346(8982):1085–7.CrossRefPubMed
25.
26.
Zurück zum Zitat Deegan T, Owen R, Holt T, et al. Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods. J Med Imaging Radiat Oncol. 2015;59(1):91–8.CrossRefPubMed Deegan T, Owen R, Holt T, et al. Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods. J Med Imaging Radiat Oncol. 2015;59(1):91–8.CrossRefPubMed
27.
Zurück zum Zitat Moseley DJ, White EA, Wiltshire KL, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67(3):942–53.CrossRefPubMedPubMedCentral Moseley DJ, White EA, Wiltshire KL, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67(3):942–53.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Barney BM, Lee RJ, Handrahan D, et al. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys. 2011;80(1):301–5.CrossRefPubMed Barney BM, Lee RJ, Handrahan D, et al. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys. 2011;80(1):301–5.CrossRefPubMed
29.
Zurück zum Zitat Nijkamp J, Pos FJ, Nuver TT, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys. 2008;70(1):75–82.CrossRefPubMed Nijkamp J, Pos FJ, Nuver TT, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys. 2008;70(1):75–82.CrossRefPubMed
30.
Zurück zum Zitat Vargas C, Yan D, Kestin LL, et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys. 2005;63(1):141–9.CrossRefPubMed Vargas C, Yan D, Kestin LL, et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys. 2005;63(1):141–9.CrossRefPubMed
31.
Zurück zum Zitat Hoogeman MS, van Herk M, de Bois J, et al. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol. 2005;74(2):177–85.CrossRefPubMed Hoogeman MS, van Herk M, de Bois J, et al. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol. 2005;74(2):177–85.CrossRefPubMed
32.
Zurück zum Zitat Langenhuijsen JF, van Lin EN, Kiemeney LA, et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys. 2007;69(3):671–6.CrossRefPubMed Langenhuijsen JF, van Lin EN, Kiemeney LA, et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys. 2007;69(3):671–6.CrossRefPubMed
33.
Zurück zum Zitat Gill S, Li J, Thomas J, et al. Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy. Br J Radiol. 1015;2012(85):1011–7. Gill S, Li J, Thomas J, et al. Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy. Br J Radiol. 1015;2012(85):1011–7.
34.
Zurück zum Zitat Poggi MM, Gant DA, Sewchand W, et al. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys. 2003;56(5):1248–51.CrossRefPubMed Poggi MM, Gant DA, Sewchand W, et al. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys. 2003;56(5):1248–51.CrossRefPubMed
35.
Zurück zum Zitat Fawaz ZS, Yassa M, Nguyen DH, et al. Fiducial marker implantation in prostate radiation therapy: complication rates and technique. Cancer Radiother. 2014;18(8):736–9.CrossRefPubMed Fawaz ZS, Yassa M, Nguyen DH, et al. Fiducial marker implantation in prostate radiation therapy: complication rates and technique. Cancer Radiother. 2014;18(8):736–9.CrossRefPubMed
36.
Zurück zum Zitat Crijns W, Van Herck H, Defraene G, et al. Dosimetric adaptive IMRT driven by fiducial points. Med Phys. 2014;41(6):061716.CrossRefPubMed Crijns W, Van Herck H, Defraene G, et al. Dosimetric adaptive IMRT driven by fiducial points. Med Phys. 2014;41(6):061716.CrossRefPubMed
Metadaten
Titel
Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
verfasst von
Berna A. Yildirim
Cem Onal
Yemliha Dolek
Publikationsdatum
11.10.2016
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 1/2017
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-016-0590-y

Weitere Artikel der Ausgabe 1/2017

Japanese Journal of Radiology 1/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.